Vivli Nonprofit Hopes To Be One-Stop Shop For Clinical Trial Data
Executive Summary
GlaxoSmithKline, Pfizer, and Biogen are among those participating in new data-sharing and analytics platform; 2,500 trials currently available to researchers.
You may also be interested in...
Clinical Trial Data Sharing: IOM Envisions Open And Closed Doors
Institute of Medicine report calls for greater, faster availability of full clinical trial data sets, but with no authority and many loopholes, impact on status quo may be minimal.
Clinical Trial Data Disclosure: As EMA Pushes For Patient Level Info, What Control Will Firms Have?
European Medicines Agency plans to require publication of all raw clinical trial data as of January 2014. While industry fears this policy will result in release of confidential commercial information, GSK is making patient-level data available to certain researchers.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.